Moors & Cabot’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $560K | Sell |
|
|||||
|
2025
Q1 | $591K | Sell |
|
|||||
|
2024
Q4 | $530K | Buy |
|
|||||
|
2024
Q3 | $560K | Buy |
|
|||||
|
2024
Q2 | $551K | Sell |
|
|||||
|
2024
Q1 | $571K | Buy |
|
|||||
|
2023
Q4 | $567K | Buy |
|
|||||
|
2023
Q3 | $567K | Buy |
|
|||||
|
2023
Q2 | $574K | Sell |
|
|||||
|
2023
Q1 | $750K | Buy |
|
|||||
|
2022
Q4 | $730K | Buy |
|
|||||
|
2022
Q3 | $580K | Sell |
|
|||||
|
2022
Q2 | $735K | Buy |
|
|||||
|
2022
Q1 | $719K | Buy |
|
|||||
|
2021
Q4 | $614K | Buy |
|
|||||
|
2021
Q3 | $600K | Sell |
|
|||||
|
2021
Q2 | $621K | Sell |
|
|||||
|
2021
Q1 | $554K | Sell |
|
|||||
|
2020
Q4 | $563K | Buy |
|
|||||
|
2020
Q3 | $603K | Sell |
|
|||||
|
2020
Q2 | $706K | Sell |
|
|||||
|
2020
Q1 | $600K | Sell |
|
|||||
|
2019
Q4 | $756K | Buy |
|
|||||
|
2019
Q3 | $665K | Buy |
|
|||||
|
2019
Q2 | $615K | Buy |
|
|||||
|
2019
Q1 | $488K | Buy |
|
|||||
|
2018
Q4 | $410K | Sell |
|
|||||
|
2018
Q3 | $442K | Sell |
|
|||||
|
2018
Q2 | $396K | Sell |
|
|||||
|
2018
Q1 | $438K | Buy |
|
|||||
|
2017
Q4 | $427K | Sell |
|
|||||
|
2017
Q3 | $501K | Sell |
|
|||||
|
2017
Q2 | $610K | Buy |
|
|||||
|
2017
Q1 | $533K | Buy |
|
|||||
|
2016
Q4 | $441K | Buy |
|
|||||
|
2016
Q3 | $492K | Buy |
|
|||||
|
2016
Q2 | $340K | Sell |
|
|||||
|
2016
Q1 | $364K | Buy |
|
|||||
|
2015
Q4 | $438K | Buy |
|
|||||
|
2015
Q3 | $407K | Sell |
|
|||||
|
2015
Q2 | $440K | Buy |
|
|||||
|
2015
Q1 | $452K | Buy |
|
|||||
|
2014
Q4 | $443K | Buy |
|
|||||
|
2014
Q3 | $336K | Hold |
|
|||||
|
2014
Q2 | $351K | Sell |
|
|||||
|
2014
Q1 | $354K | Buy |
|